Michael T. McCaul bought Novartis AG ADR (NYSE: NVS)
Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 14 trades in Novartis AG ADR (NVS) since 2014, 3 purchases and 11 sales, worth an estimated $277K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Michael T. McCaul bought $15,001 - $50,000 of Novartis AG ADR (NYSE: NVS) on October 22, 2014. Since that trade, NVS is up +209.51% against the S&P 500 up +359.66%, an outperformance of -150.15%.
Across these filings, Michael T. McCaul has been a net seller of NVS (a buy-to-sell ratio of 0.27). The most recent disclosed NVS transaction shown was dated June 23, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Michael T. McCaul's NVS trades vs the price
NVS is up +209.51% since Michael T. McCaul bought on October 22, 2014, versus +359.66% for the S&P 500.
Performance since this trade
All Michael T. McCaul NVS trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Michael T. McCaul & NVS trading FAQ
Is it legal for Michael T. McCaul to trade Novartis AG ADR (NVS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novartis AG ADR (NVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Michael T. McCaul buy NVS?
Michael T. McCaul disclosed a purchase of $15,001 - $50,000 of Novartis AG ADR (NVS) on October 22, 2014, according to public STOCK Act filings.
How has NVS performed since Michael T. McCaul's trade?
Since Michael T. McCaul bought NVS on October 22, 2014, the stock is up +209.51%, versus +359.66% for the S&P 500 over the same period, an outperformance of -150.15%.
How many times has Michael T. McCaul traded NVS?
Michael T. McCaul has disclosed 14 NVS trades since 2014 (3 purchases and 11 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVS trades?
Quantellect tracks every disclosed congressional trade in Novartis AG ADR (NVS) on the Novartis AG ADR congressional trading page, which aggregates filings across all members of Congress.
Michael T. McCaul's NVS tradesAll congressional filings for Novartis AG ADRMichael T. McCaul's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.